Responses
Regular and Young Investigator Award Abstracts
Immuno-Engineering
1207 A new oral microbial metabolite prodrug preserves CD8+ T cell stemness and improves the antitumor efficacy of immune checkpoint blockers
Compose a Response to This Article
Other responses
No responses have been published for this article.
